347 related articles for article (PubMed ID: 10496300)
1. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
White NJ; van Vugt M; Ezzet F
Clin Pharmacokinet; 1999 Aug; 37(2):105-25. PubMed ID: 10496300
[TBL] [Abstract][Full Text] [Related]
2. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
Ezzet F; Mull R; Karbwang J
Br J Clin Pharmacol; 1998 Dec; 46(6):553-61. PubMed ID: 9862244
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
[TBL] [Abstract][Full Text] [Related]
5. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Wernsdorfer WH
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Ezzet F; van Vugt M; Nosten F; Looareesuwan S; White NJ
Antimicrob Agents Chemother; 2000 Mar; 44(3):697-704. PubMed ID: 10681341
[TBL] [Abstract][Full Text] [Related]
7. Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; Martin JM; Lane A; Ward C; Amakye D
J Clin Pharmacol; 2002 Oct; 42(10):1147-58. PubMed ID: 12362930
[TBL] [Abstract][Full Text] [Related]
8. Understanding the pharmacokinetics of Coartem.
Djimdé A; Lefèvre G
Malar J; 2009 Oct; 8 Suppl 1(Suppl 1):S4. PubMed ID: 19818171
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
Ashley EA; Stepniewska K; Lindegårdh N; McGready R; Annerberg A; Hutagalung R; Singtoroj T; Hla G; Brockman A; Proux S; Wilahphaingern J; Singhasivanon P; White NJ; Nosten F
Trop Med Int Health; 2007 Feb; 12(2):201-8. PubMed ID: 17300626
[TBL] [Abstract][Full Text] [Related]
10. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
van Vugt M; Ezzet F; Nosten F; Gathmann I; Wilairatana P; Looareesuwan S; White NJ
Am J Trop Med Hyg; 1999 Dec; 61(6):964-7. PubMed ID: 10674679
[TBL] [Abstract][Full Text] [Related]
11. Artemether-lumefantrine: an option for malaria.
Stover KR; King ST; Robinson J
Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
13. Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.
Parikh S; Fehintola F; Huang L; Olson A; Adedeji WA; Darin KM; Morse GD; Murphy RL; Taiwo BO; Akinyinka OO; Adewole IF; Aweeka FT; Scarsi KK
Antimicrob Agents Chemother; 2015 Dec; 59(12):7852-6. PubMed ID: 26392500
[TBL] [Abstract][Full Text] [Related]
14. Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers.
Bindschedler M; Lefèvre G; Ezzet F; Schaeffer N; Meyer I; Thomsen MS
Eur J Clin Pharmacol; 2000 Aug; 56(5):375-81. PubMed ID: 11009045
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.
Mosha D; Guidi M; Mwingira F; Abdulla S; Mercier T; Decosterd LA; Csajka C; Genton B
Antimicrob Agents Chemother; 2014 Aug; 58(8):4583-92. PubMed ID: 24867986
[TBL] [Abstract][Full Text] [Related]
16. Synergism of benflumetol and artemether in Plasmodium falciparum.
Hassan Alin M; Björkman A; Wernsdorfer WH
Am J Trop Med Hyg; 1999 Sep; 61(3):439-45. PubMed ID: 10497987
[TBL] [Abstract][Full Text] [Related]
17. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
[TBL] [Abstract][Full Text] [Related]
18. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C
J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893
[TBL] [Abstract][Full Text] [Related]
19. How much fat is necessary to optimize lumefantrine oral bioavailability?
Ashley EA; Stepniewska K; Lindegårdh N; Annerberg A; Kham A; Brockman A; Singhasivanon P; White NJ; Nosten F
Trop Med Int Health; 2007 Feb; 12(2):195-200. PubMed ID: 17300625
[TBL] [Abstract][Full Text] [Related]
20. In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether.
Tanariya P; Tippawangkoso P; Karbwang J; Na-Bangchang K; Wernsdorfer WH
Br J Clin Pharmacol; 2000 May; 49(5):437-44. PubMed ID: 10792201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
